Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Juvenile Idiopathic Arthritis With Active Flare”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Ended earlyNCT00886769
What this trial is testing

Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 84
Large-scale testing (Phase 3)Study completedNCT00891046
What this trial is testing

An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 270
Large-scale testing (Phase 3)Study completedNCT00889863
What this trial is testing

Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis With Active Flare
Novartis Pharmaceuticals 177

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation